$LEA

Cardew Jason M sold $282K of LEA

Cardew Jason M (SVP and CFO) sold 2,000 shares of LEAR CORP (LEA) at $141.14 ($0.28M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cardew Jason M
Published Jun 3, 2026, 12:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 1:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LEA
Neutral
medium confidence
Mentioned
$LEA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEANeutralLow
01

Why it matters

The key trading question is whether the sale is informative. Because it is explicitly under 10b5-1, it is generally less predictive of near-term fundamentals than discretionary selling.

02

Market read

A routine, scheduled insider sale disclosed shortly after execution; typically low signal for price direction absent other catalysts.

03

What to watch

The filing does not indicate whether other insiders bought/sold around the same time or whether the sale size is unusual versus prior patterns.

Relevance 6/10Novelty 6/10Timing: Filed June 3; sale executed June 1 (use for positioning around recent trading).

Background

This is an SEC Form 4 insider transaction: CFO Jason M. Cardew sold shares via an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$LEANeutralMedium confidence
Context

LEAR Corp CFO sold 2,000 shares in an open-market transaction disclosed on a Rule 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted versus non-10b5-1 selling.

Evidence & confidence

Form 4 shows a scheduled sale (10b5-1) with no accompanying fundamental catalyst in the filing details provided.

Market effects

No sector-wide implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

10b5-1 sales can be routine liquidity events; the disclosure may not reflect negative company outlook.

Key entities

  • LEAR CORP

    Subject of the Form 4 insider transaction; CFO Jason M. Cardew sold shares.

  • Jason M. Cardew

    SVP and CFO who executed the open-market sale under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LEAMedAI 8/10

Lear (LEA) Is Down 6.0% After Hiking 2026 Guidance And Expanding Buybacks And Shelf Plans – Has The Bull Case Changed?

Lear Corp (NYSE:LEA) reported Q2 2026 results with sales of $6,209.4 million and net income of $192.8 million. The company raised full-year 2026 revenue guidance to about $23.8 billion, updated second-half operating income and margin expectations, expanded share buybacks, and filed new shelf registrations including an ESOP-related offering.

$LEAHighAI 9/10

Lear Q2 Earnings Call Highlights

Lear Corporation (NYSE:LEA) reported Q2 E-Systems sales up 2% to $1.6B, but organic sales down 2% due to lower volumes tied to certain Volkswagen and Ford Mustang Mach-E programs and Ford Escape, Focus and Corsair build-outs. Adjusted earnings rose to $91M, operating margin to 5.8%. Lear raised 2026 revenue to ~$23.8B and core operating earnings to ~$1.14B, plus FCF to ~$640M.

$LEAMedAI 8/10

Lear Corporation Q2 2026 Earnings Call Summary

Lear Corporation reported record first-half revenue above $12B, with 3% sales growth and margin expansion in E-Systems. It won $2.9B in YTD business awards, including major Audi seating. Lear raised 2026 guidance to $23.8B revenue and $1.14B core operating earnings, citing higher North American volumes and China weakness. It increased buybacks to at least $350M.

$LEAMed

Why is Lear stock tumbling today?

Lear Corp shares fell 10.5% to $130.99 after the company reported Q2 results and issued cautious forward guidance. Adjusted EPS was $4.28 vs $3.92 expected, and revenue rose to $6.2B vs $6.14B. Guidance for fiscal 2026 adjusted EBITDA was $1.7B to $1.82B, with China weakness and softer production outlook cited. A shelf registration filing was also reported.